Mechanistic modeling of the MAT2A–SRF–PARN axis reveals a SAM-independent pathway that stabilizes SRF, drives glycolysis through PI3K/AKT activation, and promotes osteosarcoma progression, highlighting MAT2A as a therapeutic target.
- Zhinan Ren
- Haoming Chen
- Runguang Li